CEBP Infection and Cancer: Biology, Therapeutics, and Prevention Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Omenn, G. S.
Right arrow Articles by Brunzell, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Omenn, G. S.
Right arrow Articles by Brunzell, J. D.

Cancer Epidemiology Biomarkers & Prevention, Vol 3, Issue 8 711-713, Copyright © 1994 by American Association for Cancer Research


ARTICLES

Long-term vitamin A does not produce clinically significant hypertriglyceridemia: results from CARET, the beta-carotene and retinol efficacy trial

GS Omenn, GE Goodman, M Thornquist and JD Brunzell
School of Public Health and Community Medicine, University of Washington, Seattle 98195.

Retinol and retinyl palmitate in the moderate doses tested in chemoprevention trials produce only a negligible increase in serum triglyceride levels. The effect is nonprogressive and is not associated with the kind of exaggerated response reported for interacting factors such as presence of diabetes mellitus and/or high baseline values for serum triglyceride concentration. These findings seem to represent an advantage for safety of retinol in relation to isotretinoin (13-cis-retinoic acid).


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
H.-Y. Huang, B. Caballero, S. Chang, A. J. Alberg, R. D. Semba, C. R. Schneyer, R. F. Wilson, T.-Y. Cheng, J. Vassy, G. Prokopowicz, et al.
The Efficacy and Safety of Multivitamin and Mineral Supplement Use To Prevent Cancer and Chronic Disease in Adults: A Systematic Review for a National Institutes of Health State-of-the-Science Conference
Ann Intern Med, September 5, 2006; 145(5): 372 - 385.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
B. Cartmel, T. E Moon, and N. Levine
Effects of long-term intake of retinol on selected clinical and laboratory indexes
Am. J. Clinical Nutrition, May 1, 1999; 69(5): 937 - 943.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Ribalta, A. E. LaVille, J. Girona, J. C. Vallve, and L. Masana
Low plasma vitamin A concentrations in familial combined hyperlipidemia
Clin. Chem., December 1, 1997; 43(12): 2379 - 2383.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. S. Omenn, G. E. Goodman, M. D. Thornquist, J. Balmes, M. R. Cullen, A. Glass, J. P. Keogh, F. L. Meyskens, B. Valanis, J. H. Williams, et al.
Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease
N. Engl. J. Med., May 2, 1996; 334(18): 1150 - 1155.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.